June 22nd 2025, 6:00pm
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
June 21st 2025, 6:00pm
Dr. Michael Serzan emphasizes the importance of clinical trial participation for patients with kidney cancer.
June 20th 2025, 3:00pm
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
June 20th 2025, 1:00pm
Dr. Rita Mukhtar and Dr. Joshua K. Sabari discuss the role of ctDNA to guide surgical decision-making after neoadjuvant chemo in breast cancer treatment.
June 19th 2025, 8:00pm
Dr. Raajit K. Rampal and Dr. Joshua K. Sabari walk through updates for patients in the treatment of blood cancers, including polycythemia vera.
June 18th 2025, 1:00pm
For patients with metastatic HR+/HER2— breast cancer, there were various trials to have come out of ASCO 2025 that are worth keeping your eye on.
June 17th 2025, 8:00pm
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
June 17th 2025, 1:00pm
Both non-small lung cancer and small cell lung cancer is a disease that now has various therapeutic options available, according to experts.
June 16th 2025, 8:00pm
Dr. Joshua K. Sabari and Jackie Herigodt sat down to discuss the importance of knowing a patient beyond their cancer diagnosis.
June 16th 2025, 1:00pm
The de-escalation of therapy helps avoid unnecessary toxicity from treatment in patients with brain cancer, explained Drs. Joshua K. Sabari and Manmeet Singh Ahluwalia.
What the Changing Seasons Taught Me About Cancer and Life
Understanding the Importance of Biomarker Testing in Lung Cancer
How to Individually Tailor Myelofibrosis Treatment Options
A Day in the Life of a Breast Cancer Survivor